Clever Leaves to Participate in Upcoming May Investor Conferences

BOCA RATON, Fla., May 11, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor conferences in May 2022:

Clever Leaves to Hold First Quarter 2022 Conference Call on May 12, 2022 at 5:00 p.m. ET

BOCA RATON, Fla., April 28, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Thursday, May 12, 2022 at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2022. The Company will provide its financial results in a press release prior to the conference call.

Clever Leaves Logo

Clever Leaves Germany GmbH Becomes a Fully Licensed Medical Cannabis Distributor in Germany

Clever Leaves Holdings Inc. to expand its capabilities into Europe’s largest medical cannabis market and gain access to around 20,000 pharmacies in Germany through its affiliate Clever Leaves Germany GmbH

Clever Leaves Holdings Inc. to expand its capabilities into Europe’s largest medical cannabis market and gain access to around 20,000 pharmacies in Germany through its affiliate Clever Leaves Germany GmbH
Clever Leaves Logo

Clever Leaves to Present at Upcoming April Investor Conferences

BOCA RATON, Fla., April 05, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor conferences in April 2022:

Clever Leaves Ready to Export Dried Flower From Colombia

BOCA RATON, Fla., April 04, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that after the issuance of Joint Resolution 539 of 2022 by the Colombian Government, it is ready to begin taking advantage of this regulatory framework and expects to export milled cannabis flower by Q3 of 2022 and high THC flower before the end of the year. The Resolution details the process and requirements for exports of medical cannabis flowers and cannabis derivatives and marks the completion of the required regulatory framework.

InterCure and Clever Leaves Announce International Strategic Partnership

Leading Global Cannabis Companies InterCure and Clever Leaves partner together to cultivate, market and distribute Pharmaceutical-Grade Medical Cannabis in the EU, Australia and Israel

Leading Global Cannabis Companies InterCure and Clever Leaves partner together to cultivate, market and distribute Pharmaceutical-Grade Medical Cannabis in the EU, Australia and Israel
Clever Leaves Logo

Clever Leaves Appoints William Muecke to Board of Directors

BOCA RATON, Fla., March 17, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced that it has appointed William Muecke to its board of directors, effective March 25, 2022, to fill the vacancy resulting from the previously announced departure of Kyle Detwiler, the Company’s current chairman and CEO, effective March 24, 2022. Muecke was also appointed to the board’s nominating and governance committee, as well as its compensation committee.